Evidence map›Paper›PMID 22259145›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2012

Assessing mucin expression and function in human ocular surface epithelia in vivo and in vitro.

Pablo Argüeso, Ilene K Gipson

Open access · greenAbstract read
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
18.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Human ocular mucins: The endowed guardians of sight.Advanced drug delivery reviews · 2022
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Mucolytic bacteria: prevalence in various pathological diseases.World journal of microbiology & biotechnology · 2021
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Pablo ArgüesoHarvard Medical School, Schepens Eye Research Institute, Boston, MA, USA. pablo.argueso@schepens.harvard.edu
Ilene K Gipson
Massachusetts Eye and Ear Infirmary · USSingapore Eye Research Institute · SG

Funding

MUCINS OF THE OCULAR SURFACER01EY003306 · NEI · SCHEPENS EYE RESEARCH INSTITUTE · PI GIPSON, ILENE K. · 1985 to 2015
$8.9M
O-Glycans on Mucins at the Ocular SurfaceR01EY014847 · NEI · SCHEPENS EYE RESEARCH INSTITUTE · PI ARGUESO, PABLO · 2003 to 2014
$4.0M
NEI NIH HHS R01 EY003306NEI NIH HHS R01 EY014847NEI NIH HHS R01EY014847NEI NIH HHS R01EY03306
6 · The paper itself

Abstract

Mucins of the corneal and conjunctival epithelia are necessary for the protection of the ocular surface against desiccation, pathogen access, and injury. Detection and quantification of mucins is important for the understanding of ocular surface diseases that cause impaired vision and, in advanced stages, blindness. Advances in the field of molecular biology have made it possible to study membrane mucins and their associated O-glycans in established cell culture models of human ocular surface epithelia. This chapter discusses procedures to detect and quantify mucin RNA and protein in biological samples, as well as methods to experimentally manipulate the epithelia in culture by shRNA, to understand the function of specific mucins. Example protocols are provided to evaluate the role of ocular surface mucins in mucosal barrier function and bacteria-host interactions.

Indexed as

Cells, CulturedEpithelium, CornealHumansMucinsMucins

Identifiers

PMID22259145
PMCPMC3480083
OpenAlexW15541802

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.